Literature DB >> 476570

Ultrastructure of a primary fibrosarcoma of the human thyroid gland.

W Y Shin, B Aftalion, E Hotchkiss, R Schenkman, J Berkman.   

Abstract

A primary fibrosarcoma of the thyroid occurring in a patient with a nodular goiter is described. Light microscopy showed interwoven bundles of spindle cells admixed with plump ovoid cells, and foci of multinucleated giant cells. Remnants of distorted thyroid follicles were found only at the periphery of the tumor. "Transitional" epithelial elements were not discernible but the tumor resembled an anaplastic giant cell carcinoma. Multiple blocks studied by electron microscopy, however, revealed that the tumor cells, including the giant cells, have the ultrastructure features of a fibroblast.

Entities:  

Mesh:

Year:  1979        PMID: 476570     DOI: 10.1002/1097-0142(197908)44:2<584::aid-cncr2820440227>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Rare Undifferentiated Tumour of Thyroid: Primary Thyroid Fibrosarcoma.

Authors:  Mehmet Veysi Bahadir; Sadullah Girgin; Cemil Göya; Hüseyin Büyükbayram; Zuhat Urakçi
Journal:  J Clin Diagn Res       Date:  2016-06-01

2.  Peripheral Nerve Sheath Tumors of the Thyroid Gland: A Series of Four Cases and a Review of the Literature.

Authors:  Lester D. R. Thompson; Bruce M. Wenig; Carol F. Adair; Clara S. Heffess
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

3.  Pulmonary Multiple Nodules: Benign or Malignant?

Authors:  Jing Liu; Xiao-Qiu Liu; Bing-Di Yan; Yan-Jun Xue; Xiao-Xiao Han; Han Li; Li Ma; Jie Zhang; Jun-Ling Yang
Journal:  Chin Med J (Engl)       Date:  2018-08-20       Impact factor: 2.628

Review 4.  Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.

Authors:  Moira Ragazzi; Alessia Ciarrocchi; Valentina Sancisi; Greta Gandolfi; Alessandra Bisagni; Simonetta Piana
Journal:  Int J Endocrinol       Date:  2014-08-21       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.